EarlySense Monitoring Device Evaluation on CHF Patients

NCT00382746 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-07-19

No results posted yet for this study

Summary

CHF patients will be monitored using EarlySense ES-16 device and will simultaneously fill diaries and log their weight daily. The data collected and analyzed by the ES-16 device will be correlated with the CHF status data.

Conditions

  • Congestive Heart Failure

Interventions

DEVICE

EarlySense monitoring device

Sponsors & Collaborators

  • Rambam Health Care Campus

    collaborator OTHER
  • EarlySense Ltd.

    lead INDUSTRY

Principal Investigators

  • Shmuel Rispler, M.D. · Rambam Health Care Campus

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2007-11-30
Completion
2008-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00382746 on ClinicalTrials.gov